These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27799135)

  • 1. Drug-induced cutaneous lupus erythematosus: 88 new cases.
    Laurinaviciene R; Sandholdt LH; Bygum A
    Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
    Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
    Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rowell's Syndrome Triggered by Omeprazole.
    Pozharashka J; Dourmishev L; Balabanova M; Vassileva S; Miteva L
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):124-126. PubMed ID: 31351509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update in drug-induced subacute cutaneous lupus erythematosus.
    Michaelis TC; Sontheimer RD; Lowe GC
    Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.
    Sontheimer RD; Henderson CL; Grau RH
    Arch Dermatol Res; 2009 Jan; 301(1):65-70. PubMed ID: 18797894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
    Deng Z; Guo A; Wu C; Wang C
    J Cosmet Dermatol; 2022 Dec; 21(12):7202-7208. PubMed ID: 36214602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.
    Sandholdt LH; Laurinaviciene R; Bygum A
    Br J Dermatol; 2014 Feb; 170(2):342-51. PubMed ID: 24547721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [When drugs induce cutaneous lupus erythematosus].
    Skovmøller KB; Bygum A
    Ugeskr Laeger; 2018 Oct; 180(41):. PubMed ID: 30327081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.
    Grönhagen CM; Fored CM; Linder M; Granath F; Nyberg F
    Br J Dermatol; 2012 Aug; 167(2):296-305. PubMed ID: 22458771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes.
    Poh YJ; Alrashid A; Sangle SR; Higgins E; Benton E; McGibbon D; D'Cruz DP
    Lupus; 2022 Aug; 31(9):1078-1083. PubMed ID: 35635045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate induced subacute cutaneous lupus erythematosus successfully treated with intravenous immunoglobulin.
    Uzuncakmak TK; Bayazit S; Askin O; Engin B; Ugurlu S; Sar M; Serdaroglu S
    Dermatol Ther; 2020 Nov; 33(6):e14477. PubMed ID: 33125828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced Subacute Cutaneous Lupus Erythematosus Caused by a Topical Beta Blocker - Timolol.
    Bilewicz-Stebel M; Miziołek B; Bergler-Czop B; Stańkowska A
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):44-47. PubMed ID: 29782299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.